Showing results (41-50 of 168) with videos related to
Sort By:
Pageof 17
Annals of Clinical Biochemistry|April 2, 2005
First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assaysKevin SpencerPrenatal Diagnosis|October 16, 2002
Between pregnancy biological variability of first trimester markers of Down syndrome and the implications for screening in subsequent pregnancies: an issue revisitedKevin SpencerPrenatal Diagnosis|March 29, 2002
Accuracy of Down syndrome risks produced in a first-trimester screening programme incorporating fetal nuchal translucency thickness and maternal serum biochemistryKevin SpencerScandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 2, 2014
Screening for Down syndromeKevin SpencerPrenatal Diagnosis|January 7, 2011
Maternal thyroid function at 11-13 weeks of gestation in fetal trisomies 21 and 18Ghalia Ashoor, Nerea Maiz, Howard Cuckle, et al.Obstetrical & Gynecological Survey|November 7, 2013
Down syndrome screening in assisted conception twins: an iatrogenic medical challengeIdo Ben-Ami, Ron Maymon, Ran Svirsky, et al.Clinical Proteomics|April 17, 2015
Direct and rapid mass spectral fingerprinting of maternal urine for the detection of Down syndrome pregnancyRay K Iles, Maryam E Shahpari, Howard Cuckle, et al.Prenatal Diagnosis|August 21, 2007
Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 testsMichal Berkenstadt, Liat Ries-Levavi, Howard Cuckle, et al.Plos One|May 21, 2020
Late pregnancy screening for preeclampsia with a urinary point-of-care test for misfolded proteinsXing-Min Li, Xue-Min Liu, Jun Xu, et al.Prenatal Diagnosis|October 15, 2003
First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markersFrançoise Muller, Clarisse Benattar, François Audibert, et al.Pageof 17